SCIENCE AT THE SHINE DOME 2005: ANNUAL SYMPOSIUM
Recent advances in stem cell science and therapies
6 May 2005
Closing remarks
by Dr Jim Peacock
I am not going to attempt to
summarise the whole day. I will make just a couple of comments.
What a fantastic day it has been,
really a wonderful unfolding of what is happening in this field. This has been important because we have had a
good sprinkling of some of the departmental and other government staff who will
be concerned with the review of legislation later this year.
What came through to me most of
all, in all of the talks, was the scientific honesty. There wasn’t any undue
hype. There are marvellous new developments unfolding, and the prospects for
clinical use are there, but they are being looked at with the most stringent
reality checks. This is very important.
A critical point, as I think
everyone here would agree, is that there shouldn’t be any circumstance where we
will restrict basic research in this area. We need to have new knowledge in
order to increase the possible ways of helping suffering people.
The other thing that came through
clearly, is that the status quo our current level of knowledge is not
enough. It is not acceptable for us to
stay at our present knowledge level. I
think Julian Savulescu’s talk put this very well indeed. We need to strive to
optimise or maximise the ways to improve an individual’s quality of life.
As Bob Williamson has indicated, we
need to be sure that, we have satisfactory regulatory mechanisms at each level
of this research and its potential use. What does satisfactory mean? Most of
all, it implies public confidence and understanding of the relative level of
potential benefits and risks. This is
something very difficult to achieve.
A point that came up towards the
end of the symposium is that it is important to get the words and definitions
clearly understood. Sometimes in an
audience like this we might get a little energetic with people arguing about
what is the definition of this or that, but to someone outside this field there
must be no doubt as to what we are talking about. Words matter a lot. I
think someone has already mentioned today that ‘therapeutic cloning’ perhaps is
a term we don’t need. I subscribe to this,
having heard what some people assume it means. So we need to be very careful in
preparing our arguments and our presentations.
In order for sensible progress to
be made we need to progress our research and technology, ethics, along with
regulation and responsibility areas. There
is a nexus between these different topics. Another important word is ‘votes’. How we address this particular
aspect is something that we need to think about very carefully indeed. In fact,
I think it may well have been the major spanner in certain situations in
Australia in the past.
But I don’t think we need be too
gloomy, either. Like John White, I see a big change evolution of our
knowledge, for the better. The increased understanding is changing our
attitudes. We have to do everything we
can to make the most of today’s presentations. We will!
I invite you all to thank the
speakers for treating us today and thanks to the organising committee for
putting together one of the most important symposia we have had in Australia.
|